Onset of MELAS due to the m.3243ANG mutation is early if the large phenotypic variability is considered ☆ , ☆☆
mutation, why physicians could have suspected a mitochondrial disorder (MID) much earlier [3] . When did nausea and migraine start?
A mainstay of treating MIDs is the avoidance of mitochondrion-toxic drugs [4] . Why did the patient receive phenytoin, of which it is wellknown that it has mitochondrion-toxic properties and should be avoided in MIDs [4] . Why does she require four antiepileptic drugs (AEDs)? Was ever a monotherapy with increased lamotrigine tried?
The patient complains about generalised fatigue during follow-up [1] . Is levetiracetam or clonazepam the culprit?
Overall, SLEs require MRI documentation, the patient might profit from modification of her AED-therapy, and all phenotypic manifestations should be considered when diagnosing MELAS.
